Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429 · see citing works

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · see citing works

The biology <b>,</b> function <b>,</b> and biomedical applications of exosomes

Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770 · see citing works

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · see citing works

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609 · cited 2× · see citing works

Biological properties of extracellular vesicles and their physiological functions

Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926 · see citing works

Triple-negative breast cancer: clinical features and patterns of recurrence

Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., & Narod, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3045 · Cited by 5,091 · see citing works

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001 · see citing works

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · see citing works

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Welsh, J. A., Goberdhan, D. C. I., O'Driscoll, L., Buzas, E. I., Blenkiron, C., Bussolati, B., Cai, H., Di Vizio, D., Driedonks, T. A. P., Erdbrügger, U., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12404 · Cited by 4,663 · see citing works

Mechanisms of angiogenesis and arteriogenesis

Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,146 · see citing works

The cancer genome

Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,458 · see citing works

MYC on the Path to Cancer

Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390 · see citing works

Impact of Nanotechnology on Drug Delivery

Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,364 · see citing works

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,167 · see citing works

Reassessment of exosome composition

Jeppesen, D. K., Fenix, A. M., Franklin, J. L., Higginbotham, J. N., Zhang, Q., Zimmerman, L. J., Liebler, D. C., Ping, J., Liu, Q., Evans, R., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.029 · Cited by 2,975 · see citing works

Routes and mechanisms of extracellular vesicle uptake

Mulcahy, L. A., Pink, R. C., & Carter, D. R. F. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24641 · Cited by 2,832 · see citing works

Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer

Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639 · see citing works

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D. B., Tolcher, A. W., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,508 · see citing works

Exosomes as drug delivery vehicles for Parkinson’s disease therapy

Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009 · see citing works

Progress in Exosome Isolation Techniques

Li, P., Kaslan, M., Lee, S. H., Yao, J. D., & Gao, Z. (2017) · Theranostics · doi:10.7150/thno.18133 · Cited by 1,970 · see citing works

The exosome journey: from biogenesis to uptake and intracellular signalling

Gurung, S., Perocheau, D. P. B., Touramanidou, L., & Baruteau, J. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00730-1 · Cited by 1,821 · see citing works

A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy

Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,809 · see citing works

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation

Kamaly, N., Xiao, Z., Valencia, P. M., Radovic‐Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,734 · see citing works

Optimized exosome isolation protocol for cell culture supernatant and human plasma

Lobb, R. J., Becker, M., Wen, S., Wong, C. S. F., Wiegmans, A. P., Leimgruber, A., & Möller, A. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27031 · Cited by 1,725 · see citing works

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00193 · Cited by 1,617 · see citing works

PD-1/PD-L1 pathway: current researches in cancer.

Han, Y., Liu, D., & Li, L. (2020) · PubMed Central · Cited by 1,602 · see citing works

Therapeutic siRNA: state of the art

Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586 · see citing works

A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes

Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W. E., Miller, D., & Zhang, H. (2010) · Molecular Therapy · doi:10.1038/mt.2010.105 · Cited by 1,579 · see citing works

The current state and future directions of RNAi-based therapeutics

Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443 · see citing works

Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., & Birchmeier, C. (1995) · Nature · doi:10.1038/376768a0 · Cited by 1,284 · see citing works

Extracellular vesicles for drug delivery.

Vader, P., Mol, E. A., Pasterkamp, G., & Schiffelers, R. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.006 · Cited by 1,237 · see citing works

The roles of extracellular vesicles in the immune system

Buzás, E. I. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00763-8 · Cited by 1,236 · see citing works

Exosomes: key players in cancer and potential therapeutic strategy

Dai, J., Su, Y., Zhong, S., Cong, L., Liu, B., Yang, J., Tao, Y., He, Z., Chen, C., & Jiang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00261-0 · Cited by 1,186 · see citing works

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.

Desai, N. P., Trieu, V. N., Yao, Z., Louie, L. G., Ci, S., Yang, A. J., Tao, C., De, T., Beals, B., Dykes, D. J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1634 · Cited by 1,183 · see citing works

Engineering exosomes as refined biological nanoplatforms for drug delivery

Luan, X., Sansanaphongpricha, K., Myers, I., Chen, H., Yuan, H., & Sun, D. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.12 · Cited by 1,171 · see citing works

Multivalent <i>N</i> -Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing

Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141 · see citing works

KRAS Mutation: From Undruggable to Druggable in Cancer

Huang, L., Guo, Z., Wang, F., & Fu, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00780-4 · Cited by 1,127 · see citing works

Using exosomes, naturally-equipped nanocarriers, for drug delivery

Batrakova, E. V., & Kim, M. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.030 · Cited by 1,122 · see citing works

The Smart Drug Delivery System and Its Clinical Potential

Liu, D., Yang, F., Xiong, F., & Gu, N. (2016) · Theranostics · doi:10.7150/thno.14858 · Cited by 1,066 · see citing works

Hypoxic enhancement of exosome release by breast cancer cells

King, H. W., Michael, M. Z., & Gleadle, J. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-421 · Cited by 1,045 · see citing works

Plant-derived exosomal MicroRNAs shape the gut microbiota

Teng, Y., Ren, Y., Sayed, M., Hu, X., Lei, C., Kumar, A., Hutchins, E., Mu, J., Deng, Z., Luo, C., et al. (2018) · Cell Host &amp; Microbe · doi:10.1016/j.chom.2018.10.001 · Cited by 1,027 · see citing works

The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells

Liu, R., Wang, X., Chen, G., Dalerba, P. D., Gurney, A. L., Hoey, T. C., Sherlock, G. J., Lewicki, J. A., Shedden, K., & Clarke, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063994 · Cited by 984 · see citing works

The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic

Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 979 · see citing works

Bovine milk-derived exosomes for drug delivery

Munagala, R., Aqil, F., Jeyabalan, J., & Gupta, R. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.020 · Cited by 936 · see citing works

Drugging the ‘undruggable’ cancer targets

Dang, C. V., Reddy, E. P., Shokat, K. M., & Soucek, L. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.36 · Cited by 927 · see citing works

A Review of Exosomal Isolation Methods: Is Size Exclusion Chromatography the Best Option?

Sidhom, K., Obi, P. O., & Saleem, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186466 · Cited by 908 · see citing works

Survivin, versatile modulation of cell division and apoptosis in cancer

Altieri, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207113 · Cited by 899 · see citing works

Grape Exosome-like Nanoparticles Induce Intestinal Stem Cells and Protect Mice From DSS-Induced Colitis

Ju, S., Mu, J., Dokland, T., Zhuang, X., Wang, Q., Jiang, H., Xiang, X., Deng, Z., Wang, B., Zhang, L., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.64 · Cited by 880 · see citing works

Viral and nonviral delivery systems for gene delivery

Nouri, N., Talebi, M., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 861 · see citing works

Context-specific regulation of extracellular vesicle biogenesis and cargo selection

Dixson, A. C., Dawson, T. R., Vizio, D. D., & Weaver, A. M. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00576-0 · Cited by 827 · see citing works

MYC Activation Is a Hallmark of Cancer Initiation and MaintenancePreprint

Gabay, M., Li, Y., & Felsher, D. W. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014241 · Cited by 808 · see citing works

Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms

Dad, H. A., Gu, T.-W., Zhu, A.-Q., Huang, L., & Peng, L. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.030 · Cited by 761 · see citing works

The emerging shape of the ESCRT machinery

Williams, R. L., & Urbé, S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2162 · Cited by 747 · see citing works

Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation

Yang, Z., Shi, J., Xie, J., Wang, Y., Sun, J., Liu, T., Zhao, Y., Zhao, X., Wang, X., Ma, Y., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0485-1 · Cited by 744 · see citing works

Mesenchymal Stem Cells Secrete Immunologically Active Exosomes

Zhang, B., Yin, Y., Lai, R. C., Tan, S. S., Choo, A. B. H., & Lim, S. K. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0479 · Cited by 698 · see citing works

Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes

Kanwar, S. S., Dunlay, C. J., Simeone, D. M., & Nagrath, S. (2014) · Lab on a Chip · doi:10.1039/c4lc00136b · Cited by 663 · see citing works

Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles

Kooijmans, S. A. A., Stremersch, S., Braeckmans, K., de Smedt, S. C., Hendrix, A., Wood, M. J. A., Schiffelers, R. M., Raemdonck, K., & Vader, P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.014 · Cited by 663 · see citing works

siRNA delivery systems for cancer treatment

Oh, Y., & Park, T. G. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.018 · Cited by 641 · see citing works

Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source

Meng, W., He, C., Hao, Y., Wang, L., Li, L., & Zhu, G. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1748758 · Cited by 618 · see citing works

Patisiran: First Global Approval

Hoy, S. M. (2018) · Drugs · doi:10.1007/s40265-018-0983-6 · Cited by 616 · see citing works

The interplay between MYC and HIF in cancer

Dang, C. V., Kim, J., Gao, P., & Yustein, J. T. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2274 · Cited by 614 · see citing works

Exosomes Produced from 3D Cultures of MSCs by Tangential Flow Filtration Show Higher Yield and Improved Activity

Haraszti, R. A., Miller, R., Stoppato, M., Sere, Y. Y., Coles, A., Didiot, M.-C., Wollacott, R., Sapp, E., Dubuke, M. L., Li, X., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.09.015 · Cited by 567 · see citing works

Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer

Qu, Q., Zeng, F., Liu, X., Wang, Q. J., & Deng, F. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.132 · Cited by 548 · see citing works

Safety of Nanoparticles in Medicine

Wolfram, J., Zhu, M., Yang, Y. P., Shen, J., Gentile, E., Paolino, D., Fresta, M., Nie, G., Chen, C., Shen, H., et al. (2015) · Current Drug Targets · doi:10.2174/1389450115666140804124808 · Cited by 535 · see citing works

The Biology of Cancer Exosomes: Insights and New Perspectives

Ruivo, C. F., Adem, B., Silva, M. G., & Melo, S. A. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0994 · Cited by 533 · see citing works

Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids

Wang, Q., Zhuang, X., Mu, J., Deng, Z., Jiang, H., Zhang, L., Xiang, X., Wang, B., Yan, J., Miller, D., et al. (2013) · Nature Communications · doi:10.1038/ncomms2886 · Cited by 528 · see citing works

c-Met: Structure, functions and potential for therapeutic inhibition

Ma, P. C., Maulik, G., Christensen, J. G., & Salgia, R. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023768811842 · Cited by 506 · see citing works

Exosomes are natural carriers of exogenous siRNA to human cells in vitro

Shtam, T. A., Kovalev, R. A., Varfolomeeva, E. Y., Makarov, E. M., Kil, Y. V., & Filatov, M. V. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-88 · Cited by 499 · see citing works

The growth of siRNA-based therapeutics: updated clinical studies

Zhang, M. M., Bahal, R., Rasmussen, T. P., Manautou, J. E., & Zhong, X.-B. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114432 · Cited by 497 · see citing works

Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression

Pi, F., Binzel, D. W., Lee, T. J., Li, Z., Sun, M., Rychahou, P. G., Li, H., Haque, F., Wang, S., Croce, C. M., et al. (2017) · Nature Nanotechnology · doi:10.1038/s41565-017-0012-z · Cited by 495 · see citing works

Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing

Didiot, M.-C., Hall, L. M., Coles, A. H., Haraszti, R. A., Godinho, B. M., Chase, K., Sapp, E., Ly, S., Alterman, J. F., Hassler, M. R., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.126 · Cited by 483 · see citing works

Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine

Fais, S., O’Driscoll, L., Borras, F. E., Buzas, E., Camussi, G., Cappello, F., Carvalho, J., Cordeiro da Silva, A., Del Portillo, H., El Andaloussi, S., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b08015 · Cited by 481 · see citing works

Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy

Zhang, M., Xiao, B., Wang, H., Han, M. K., Zhang, Z., Viennois, É., Xu, C., & Merlin, D. (2016) · Molecular Therapy · doi:10.1038/mt.2016.159 · Cited by 458 · see citing works

Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment

Zhou, W., Zhou, Y., Chen, X., Ning, T., Chen, H., Guo, Q., Zhang, Y., Liu, P., Zhang, Y., Li, C., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120546 · Cited by 449 · see citing works

Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis

Zhao, L., Gu, C., Gan, Y. H., Shao, L., Chen, H., & Zhu, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.005 · Cited by 443 · see citing works

Survivin: a unique target for tumor therapy

Garg, H., Suri, P., Gupta, J. C., Talwar, G. P., & Dubey, S. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0326-1 · Cited by 442 · see citing works

Chemically modified siRNA: tools and applications

Watts, J. K., Deleavey, G. F., & Damha, M. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.007 · Cited by 431 · see citing works

siRNA Delivery Strategies: A Comprehensive Review of Recent Developments

Tatiparti, K., Sau, S., Kashaw, S. K., & Iyer, A. K. (2017) · Nanomaterials · doi:10.3390/nano7040077 · Cited by 429 · see citing works

Plant-derived exosome-like nanoparticles and their therapeutic activities

Kim, J., Li, S., Zhang, S., & Wang, J. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.05.006 · Cited by 412 · see citing works

Mechanisms associated with biogenesis of exosomes in cancer

McAndrews, K. M., & Kalluri, R. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0963-9 · Cited by 394 · see citing works

Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)

Whiteside, T. L. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120265 · Cited by 391 · see citing works

Efficient production and enhanced tumor delivery of engineered extracellular vesicles

Watson, D. C., Bayik, D., Srivatsan, A., Bergamaschi, C., Valentin, A., Niu, G., Bear, J., Monninger, M., Sun, M., Morales-Kastresana, A., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.003 · Cited by 385 · see citing works

Oncogene Knockdown via Active Loading of Small RNAs into Extracellular Vesicles by Sonication

Lamichhane, T. N., Jeyaram, A., Patel, D. B., Parajuli, B., Livingston, N. K., Arumugasaamy, N., Schardt, J. S., & Jay, S. M. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0457-4 · Cited by 371 · see citing works

Comparative analysis of discrete exosome fractions obtained by differential centrifugation

Jeppesen, D. K., Hvam, M. L., Primdal-Bengtson, B., Boysen, A. T., Whitehead, B. J., Dyrskjøt, L., Orntoft, T. F., Howard, K. A., & Ostenfeld, M. S. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.25011 · Cited by 369 · see citing works

Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers

Wu, Y., Deng, W., & Klinke, D. J. (2015) · The Analyst · doi:10.1039/c5an00688k · Cited by 368 · see citing works

A review of nanocarriers for the delivery of small interfering RNA

Kesharwani, P., Gajbhiye, V., & Jain, N. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.068 · Cited by 368 · see citing works

Liposomal paclitaxel formulations

Koudelka, Š., & Tuřánek, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.006 · Cited by 366 · see citing works

Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin

Federici, C., Petrucci, F., Caimi, S., Cesolini, A., Logozzi, M., Borghi, M., D’Ilio, S., Lugini, L., Violante, N., Azzarito, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088193 · Cited by 356 · see citing works

Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells

Soo, C. Y., Song, Y., Zheng, Y. H., Campbell, E. C., Riches, A., Gunn‐Moore, F. J., & Powis, S. J. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03569.x · Cited by 348 · see citing works

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

Krauss, A. C., Gao, X., Li, L., Manning, M. L., Patel, P., Fu, W., Janoria, K. G., Gieser, G., Bateman, D. A., Przepiorka, D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2990 · Cited by 336 · see citing works

Transfer of extracellular vesicles during immune cell‐cell interactions

Gutiérrez‐Vázquez, C., Villarroya‐Beltri, C., Mittelbrunn, M., & Sánchez‐Madrid, F. (2012) · Immunological Reviews · doi:10.1111/imr.12013 · Cited by 325 · see citing works

In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR/dCas9

Li, Z., Zhou, X., Wei, M., Gao, X., Zhao, L., Shi, R., Sun, W., Duan, Y., Yang, G., & Yuan, L. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b02689 · Cited by 318 · see citing works

Milk exosomes - Natural nanoparticles for siRNA delivery

Aqil, F., Munagala, R., Jeyabalan, J., Agrawal, A. K., Kyakulaga, A.-H., Wilcher, S. A., & Gupta, R. C. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.011 · Cited by 315 · see citing works

Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma

Goyal, L., Muzumdar, M. D., & Zhu, A. X. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2791 · Cited by 307 · see citing works

Recent advances in exosome-mediated nucleic acid delivery for cancer therapy

Zhang, Y., Liu, Q., Zhang, X., Huang, H., Tang, S., Chai, Y., Xu, Z., Li, M., Chen, X., Liu, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01472-z · Cited by 306 · see citing works

Oral Administration of ginger-derived Nanolipids Loaded With siRNA As a Novel Approach for Efficient siRNA Drug Delivery to Treat Ulcerative Colitis

Zhang, M., Wang, X., Han, M. K., Collins, J. F., & Merlin, D. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0196 · Cited by 305 · see citing works

Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions

Purushothaman, A., Bandari, S., Liu, J., Mobley, J. A., Brown, E. E., & Sanderson, R. D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.686295 · Cited by 304 · see citing works

Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics

Huang, Y. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2016.12.003 · Cited by 295 · see citing works

Sox2 is important for two crucial processes in lung development: Branching morphogenesis and epithelial cell differentiation

Gontan, C., Munck, A. B., Vermeij, M., Grosveld, F. G., Tibboel, D., & Rottier, R. J. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.02.035 · Cited by 294 · see citing works

Lumasiran: First Approval

Scott, L. J., & Keam, S. J. (2021) · Drugs · doi:10.1007/s40265-020-01463-0 · Cited by 293 · see citing works

Polymeric Lipid Hybrid Nanoparticles (PLNs) as Emerging Drug Delivery Platform—A Comprehensive Review of Their Properties, Preparation Methods, and Therapeutic Applications

Sivadasan, D., Sultan, M. H., Madkhali, O. A. A., Almoshari, Y., & Thangavel, N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081291 · Cited by 293 · see citing works

Plant-Derived Exosome-Like Nanovesicles: Current Progress and Prospects

Mu, N., Li, J., Zeng, L., You, J., Li, R., Qin, A., Liu, X., Fang, Y., & Zhou, Z. H. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s420748 · Cited by 278 · see citing works

RNAi Therapies: Drugging the Undruggable

Wu, S. Y., Lopez‐Berestein, G., Călin, G. A., & Sood, A. K. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008362 · Cited by 273 · see citing works

Advances in siRNA delivery in cancer therapy

Singh, A. P., Trivedi, P., & Jain, N. K. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1307210 · Cited by 272 · see citing works

Markedly Enhanced Permeability and Retention Effects Induced by Photo-immunotherapy of Tumors

Sano, K., Nakajima, T., Choyke, P. L., & Kobayashi, H. (2012) · ACS Nano · doi:10.1021/nn305011p · Cited by 265 · see citing works

Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression

Li, Z., Wang, H., Yin, H., Bennett, C. E., Zhang, H., & Guo, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-32953-7 · Cited by 264 · see citing works

Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment

Yi, Q., Xu, Z., Thakur, A., Zhang, K., Liang, Q., Liu, Y., & Yan, Y. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106733 · Cited by 258 · see citing works

Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines

Yang, C., Zhang, M., & Merlin, D. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb03207b · Cited by 256 · see citing works

Drug delivery of siRNA therapeutics: potentials and limits of nanosystems

Reischl, D., & Zimmer, A. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.06.001 · Cited by 253 · see citing works

Clinical Application of Drug Delivery Systems in Cancer Chemotherapy: Review of the Efficacy and Side Effects of Approved Drugs

Iwamoto, T. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-01102 · Cited by 247 · see citing works

Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells

Melzer, C., Rehn, V., Yang, Y., Bähre, H., von der Ohe, J., & Hass, R. (2019) · Cancers · doi:10.3390/cancers11060798 · Cited by 246 · see citing works

Engineered Exosomes for Targeted Transfer of siRNA to HER2 Positive Breast Cancer Cells

Khodashenas, S., Moghadam, M. F., Moazzeni, S. M., Gomari, H., & Salimi, F. (2018) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-018-2813-4 · Cited by 243 · see citing works

HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence

Fu, J., Su, X., Li, Z., Deng, L., Liu, X., Feng, X., & Peng, J. (2021) · Oncogene · doi:10.1038/s41388-021-01863-w · Cited by 235 · see citing works

Targeting KRAS mutant cancers: from druggable therapy to drug resistance

Zhu, C., Guan, X., Zhang, X., Luan, X., Song, Z., Cheng, X., Zhang, W., & Qin, J.-J. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01629-2 · Cited by 231 · see citing works

Plant-Derived Exosomal Nanoparticles Inhibit Pathogenicity of Porphyromonas gingivalis

Sundaram, K., Miller, D. P., Kumar, A., Teng, Y., Sayed, M. E., Mu, J., Lei, C., Sriwastva, M. K., Zhang, L., Yan, J., et al. (2019) · iScience · doi:10.1016/j.isci.2019.10.032 · Cited by 226 · see citing works

A protocol for designing siRNAs with high functionality and specificity

Birmingham, A., Anderson, E. M., Sullivan, K., Reynolds, A., Boese, Q., Leake, D., Karpilow, J. M., & Khvorova, A. (2007) · Nature Protocols · doi:10.1038/nprot.2007.278 · Cited by 222 · see citing works

Biological properties of plant-derived extracellular vesicles

Rome, S. (2019) · Food & Function · doi:10.1039/c8fo02295j · Cited by 221 · see citing works

Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation

Yang, Z., Xie, J., Zhu, J., Chen, K., Chiang, C., Wang, X., Wang, X., Kuang, T., Chen, F., Chen, Z., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.008 · Cited by 217 · see citing works

Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics

Kar, R., Dhar, R., Mukherjee, S., Nag, S., Gorai, S., Mukerjee, N., Mukherjee, D., Vatsa, R., Jadhav, M., Ghosh, A., et al. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01329 · Cited by 217 · see citing works

The Metastasis-Associated Gene S100A4 Is a Novel Target of β-catenin/T-cell Factor Signaling in Colon Cancer

Stein, U., Arlt, F., Walther, W., Smith, J. L., Waldman, T. A., Harris, E. D., Mertins, S. D., Heizmann, C. W., Allard, D., Birchmeier, W., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.041 · Cited by 214 · see citing works

Evidence That SOX2 Overexpression Is Oncogenic in the Lung

Lu, Y., Futtner, C. R., Rock, J. R., Xu, X., Whitworth, W., Hogan, B. L. M., & Onaitis, M. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011022 · Cited by 213 · see citing works

A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy

Dong, Y., Yu, T., Ding, L., Laurini, E., Huang, Y., Zhang, M., Weng, Y., Lin, S., Chen, P., Marson, D., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b10021 · Cited by 213 · see citing works

A review of clinical aspects of breast cancer

Libson, S., & Lippman, M. E. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.852971 · Cited by 211 · see citing works

Exosomes and Immune Response in Cancer: Friends or Foes?

Barros, F. M., Carneiro, F., Machado, J. C., & Melo, S. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00730 · Cited by 202 · see citing works

Expression of c‐met/HGF Receptor in Human Non‐small Cell Lung Carcinomas in vitro and in vivo and Its Prognostic Significance

Ichimura, E., Maeshima, A., Nakajima, T., & Nakamura, T. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb03111.x · Cited by 201 · see citing works

Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer.

Nogawa, M., Yuasa, T., Kimura, S., Tanaka, M., Kuroda, J., Sato, K., Yokota, A., Segawa, H., Toda, Y., Kageyama, S., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23043 · Cited by 197 · see citing works

Exosomes and the Emerging Field of Exosome-Based Gene Therapy

O’Loughlin, A. J., Woffindale, C., & Wood, M. J. A. (2012) · Current Gene Therapy · doi:10.2174/156652312802083594 · Cited by 193 · see citing works

Precise and efficient siRNA design: a key point in competent gene silencing

Fakhr, E., Zare, F., & Teimoori‐Toolabi, L. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.4 · Cited by 192 · see citing works

Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options

van Andel, H., Kocemba, K. A., Spaargaren, M., & Pals, S. T. (2019) · Leukemia · doi:10.1038/s41375-019-0404-1 · Cited by 188 · see citing works

Onivyde for the therapy of multiple solid tumors

Zhang, H. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s105587 · Cited by 187 · see citing works

S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence

Mishra, S. K., Siddique, H. R., & Saleem, M. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9338-4 · Cited by 185 · see citing works

Efficient nanocarriers of siRNA therapeutics for cancer treatment

Subhan, M. A., & Torchilin, V. P. (2019) · Translational research · doi:10.1016/j.trsl.2019.07.006 · Cited by 182 · see citing works

Harnessing in vivo siRNA delivery for drug discovery and therapeutic development

Xie, F. Y., Woodle, M. C., & Lu, P. Y. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03668-8 · Cited by 175 · see citing works

Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy

Wang, Y., Xie, Y., Kilchrist, K. V., Li, J., Duvall, C. L., & Oupický, D. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b21214 · Cited by 175 · see citing works

The ups and downs of Myc biology

Soucek, L., & Evan, G. I. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.001 · Cited by 170 · see citing works

Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle

Yan, W., & Jiang, S. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.02.013 · Cited by 170 · see citing works

The complete sequence of a human genomePreprint

Nurk, S., Koren, S., Rhie, A., Rautiainen, M., Bzikadze, A. V., Mikheenko, A., Vollger, M. R., Altemose, N., Uralsky, L. I., Gershman, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.26.445798 · Cited by 169 · see citing works

PLK-1 Silencing in Bladder Cancer by siRNA Delivered With Exosomes

Greco, K. A., Franzen, C. A., Foreman, K. E., Flanigan, R. C., Kuo, P. C., & Gupta, G. N. (2016) · Urology · doi:10.1016/j.urology.2016.01.028 · Cited by 164 · see citing works

The multifaceted activity of VEGF in angiogenesis – Implications for therapy responses

Moens, S., Goveia, J., Stapor, P. C., Cantelmo, A. R., & Carmeliet, P. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.009 · Cited by 159 · see citing works

Multivesicular body formation enhancement and exosome release during endoplasmic reticulum stress

Kanemoto, S., Nitani, R., Murakami, T., Kaneko, M., Asada, R., Matsuhisa, K., Saito, A., & Imaizumi, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.019 · Cited by 158 · see citing works

Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside

Wu, K., Xing, F., Wu, S.-Y., & Watabe, K. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.10.001 · Cited by 157 · see citing works

The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery

Anson, D. S. (2004) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-2-9 · Cited by 154 · see citing works

Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor si RNA

Zhang, H., Wang, Y., Bai, M., Wang, J., Zhu, K., Liu, R., Ge, S., Li, J., Ning, T., Deng, T., et al. (2017) · Cancer Science · doi:10.1111/cas.13488 · Cited by 153 · see citing works

The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy

Passero, F. C., Grapsa, D., Syrigos, K., & Saif, M. W. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2016.1192471 · Cited by 150 · see citing works

Biological Features of Extracellular Vesicles and Challenges

Zeng, Y., Qiu, Y., Jiang, W., Shen, J., Yao, X., He, X., Li, L., Fu, B. M., & Liu, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.816698 · Cited by 147 · see citing works

Biological properties and therapeutic effects of plant-derived nanovesicles

Gioia, S. D., Hossain, M. N., & Conese, M. (2020) · Open Medicine · doi:10.1515/med-2020-0160 · Cited by 146 · see citing works

Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells

Bai, J., Duan, J., Liu, R., Du, Y.-F., Luo, Q., Cui, Y., Su, Z.-B., Xu, J., Xie, Y., & Lü, W.-L. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.04.002 · Cited by 144 · see citing works

Exosomes derived from siRNA against GRP78 modified bone-marrow-derived mesenchymal stem cells suppress Sorafenib resistance in hepatocellular carcinoma

Li, H., Yang, C., Shi, Y., & Zhao, L. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0429-z · Cited by 143 · see citing works

Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping

Zheng, Z., Li, Z., Xu, C., Guo, B., & Guo, P. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.021 · Cited by 143 · see citing works

Blood concentrations of small extracellular vesicles are determined by a balance between abundant secretion and rapid clearance

Matsumoto, A., Takahashi, Y., Chang, H., Wu, Y.-W., Yamamoto, A., Ishihama, Y., & Takakura, Y. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1696517 · Cited by 141 · see citing works

The Emerging Role of Plant-Derived Exosomes-Like Nanoparticles in Immune Regulation and Periodontitis Treatment

Zhang, Z., Yu, Y., Zhu, G., Zeng, L., Xu, S., Cheng, H., Ouyang, Z., Chen, J., Pathak, J. L., Wu, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.896745 · Cited by 138 · see citing works

TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells

Li, W.-Q., Zhang, X., Wang, J., Li, M., Cao, C., Tan, J.-H., Ma, D., & Gao, Q.-L. (2017) · OncoTarget · doi:10.18632/oncotarget.21635 · Cited by 134 · see citing works

Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer

Han, Q., Xie, Q. R., Li, F., Cheng, Y., Wu, T., Zhang, Y., Lu, X., Wong, A. S. T., Sha, J., & Xia, W. (2021) · Theranostics · doi:10.7150/thno.53886 · Cited by 134 · see citing works

Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy

Liu, X., Zhao, H.-C., Hou, S.-J., Zhang, H., Cheng, L., Yuan, S., Zhang, L., Song, J., Zhang, S., & Chen, S. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106425 · Cited by 133 · see citing works

Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer

Zhang, P., Zhou, H., Lu, K., Lu, Y., Wang, Y., & Feng, T. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s155134 · Cited by 129 · see citing works

Preclinical development of a subcutaneous ALAS1 RNAi therapeutic for treatment of hepatic porphyrias using circulating RNA quantification

Chan, A., Liebow, A., Yasuda, M., Gan, L., Racie, T., Maier, M., Kuchimanchi, S., Foster, D., Milstein, S., Charisse, K., et al. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.36 · Cited by 128 · see citing works

Targeting MYC in multiple myeloma

Jovanović, K., Roche‐Lestienne, C., Ghobrial, I. M., Facon, T. T. F., Quesnel, B., & Manier, S. (2018) · Leukemia · doi:10.1038/s41375-018-0036-x · Cited by 128 · see citing works

In vivo self-assembled small RNAs as a new generation of RNAi therapeutics

Fu, Z., Zhang, X., Zhou, X., Ur-Rehman, U., Yu, M., Liang, H., Guo, H., Guo, X., Kong, Y., Su, Y., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00491-z · Cited by 128 · see citing works

Purification Protocols for Extracellular Vesicles

Lane, R. E., Korbie, D. J., Trau, M., & Hill, M. M. C. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7253-1_10 · Cited by 118 · see citing works

Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison

Marko, T. A., Diessner, B. J., & Spector, L. G. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.25963 · Cited by 115 · see citing works

Exosomes: Tunable Nano Vehicles for Macromolecular Delivery of Transferrin and Lactoferrin to Specific Intracellular Compartment

Malhotra, H., Sheokand, N., Kumar, S., Chauhan, A. S., Kumar, M., Jakhar, P., Boradia, V. M., Raje, C. I., & Raje, M. (2016) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2016.2229 · Cited by 114 · see citing works

Tumor Exosomes Reprogrammed by Low pH Are Efficient Targeting Vehicles for Smart Drug Delivery and Personalized Therapy against their Homologous Tumor

Gong, C., Zhang, X., Shi, M., Li, F., Wang, S., Wang, Y., Wang, Y., Wei, W., & Ma, G. (2021) · Advanced Science · doi:10.1002/advs.202002787 · Cited by 114 · see citing works

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation

Lin, D., Zhang, H., Liu, R., Deng, T., Ning, T., Bai, M., Yang, Y., Zhu, K., Wang, J., Duan, J., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13052 · Cited by 113 · see citing works

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer

Zhang, Q., Zhang, H., Ning, T., Liu, D., Deng, T., Liu, R., Bai, M., Zhu, K., Li, J., Qian, F., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s231214 · Cited by 112 · see citing works

Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus

Ortega, A., Martínez-Arroyo, O., Forner, M. J., & Cortés, R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010003 · Cited by 111 · see citing works

Plant-Derived Exosome-like Nanoparticles for Biomedical Applications and Regenerative Therapy

Sarasati, A., Syahruddin, M. H., Nuryanti, A., Ana, I. D., Barlian, A., Wijaya, C. H., Ratnadewi, D., Wungu, T. D. K., & Takemori, H. (2023) · Biomedicines · doi:10.3390/biomedicines11041053 · Cited by 111 · see citing works

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Faruqu, F. N., Xu, L., & Al‐Jamal, K. T. (2018) · Journal of Visualized Experiments · doi:10.3791/58814 · Cited by 101 · see citing works

Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery

Soltani, F., Parhiz, H., Mokhtarzadeh, A., & Ramezani, M. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666151027153410 · Cited by 99 · see citing works

PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas

Pascual, M., Mena‐Varas, M., Robles, E. F., Garcia-Barchino, M. J., Panizo, C., Hervás‐Stubbs, S., Alignani, D., Sagardoy, A., Martínez‐Ferrandis, J. I., Bunting, K. L., et al. (2019) · Blood · doi:10.1182/blood.2018889931 · Cited by 96 · see citing works

S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction

Dahlmann, M., Kobelt, D., Walther, W., Mudduluru, G., & Stein, U. (2016) · Cancers · doi:10.3390/cancers8060059 · Cited by 95 · see citing works

iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers

Zuo, H.-D. (2019) · Journal of Oncology · doi:10.1155/2019/9367845 · Cited by 95 · see citing works

Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia

Hu, B., Li, B., Li, K., Liu, Y., Li, C., Zheng, L., Zhang, M., Yang, T., Guo, S., Dong, X., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm1418 · Cited by 95 · see citing works

Exosome Release by Primary B Cells

McLellan, A. D. (2009) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v29.i3.20 · Cited by 89 · see citing works

Engineered Exosomes for Tumor-Targeted Drug Delivery: A Focus on Genetic and Chemical Functionalization

Akbari, A., Nazari‐Khanamiri, F., Ahmadi, M., Shoaran, M., & Rezaie, J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010066 · Cited by 89 · see citing works

Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells

Ummanni, R., Teller, S., Junker, H., Zimmermann, U., Venz, S., Scharf, C., Giebel, J., & Walther, R. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06697.x · Cited by 84 · see citing works

Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer

Kaban, K., Hinterleitner, C., Zhou, Y., Şalva, E., Kantarcı, A. G., Salih, H. R., & Märklin, M. (2021) · Cancers · doi:10.3390/cancers13102397 · Cited by 83 · see citing works

Application of plant-derived exosome-like nanoparticles in drug delivery

Barzin, M., Bagheri, A. M., Ohadi, M., Abhaji, A. M., Salarpour, S., & Dehghannoudeh, G. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2202242 · Cited by 83 · see citing works

Plant and mammalian-derived extracellular vesicles: a new therapeutic approach for the future

Sall, I. M., & Tăbăran, F. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1215650 · Cited by 83 · see citing works

Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer

Fristrup, N., Ulhøi, B. P., Birkenkamp‐Demtröder, K., Mansilla, F., Sänchez‐Carbayo, M., Segersten, U., Malmström, P., Hartmann, A., Palou, J., Álvarez-Múgica, M., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.023 · Cited by 82 · see citing works

Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatment

Xu, L., Faruqu, F. N., Lim, Y. M., Lim, K. Y., Liam‐Or, R., Walters, A. A., Lavender, P., Fear, D. J., Wells, C. M., Wang, J. T.-W., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120369 · Cited by 80 · see citing works

Purposing plant-derived exosomes-like nanovesicles for drug delivery: patents and literature review

Orefice, N. S., Raimo, R. D., Mizzoni, D., Logozzi, M., & Fais, S. (2023) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2023.2195093 · Cited by 80 · see citing works

Novel Hydrophobically Modified Asymmetric RNAi Compounds (sd-rxRNA) Demonstrate Robust Efficacy in the Eye

Byrne, M., Tzekov, R. T., Wang, Y., Rodgers, A., Cardia, J. P., Ford, G., Holton, K., Pandarinathan, L., Lapierre, J., Stanney, W., et al. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0148 · Cited by 78 · see citing works

Large and small extracellular vesicles released by glioma cells in vitro and in vivo

Yekula, A., Minciacchi, V. R., Morello, M., Shao, H., Park, Y., Zhang, X., Muralidharan, K., Freeman, M. R., Weissleder, R., Lee, H., et al. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1689784 · Cited by 77 · see citing works

Current research progress in targeted anti‐angiogenesis therapy for osteosarcoma

Liu, Y., Huang, N., Liao, S., Rothzerg, E., Yao, F., Li, Y., Wood, D., & Xu, J. (2021) · Cell Proliferation · doi:10.1111/cpr.13102 · Cited by 76 · see citing works

S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2

Liu, L., Qi, L., Knifley, T., Piecoro, D. W., Rychahou, P. G., Liu, J., Mitov, M. I., Martin, J. T., Wang, C., Wu, J., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004365 · Cited by 74 · see citing works

Plant-derived exosomes: a green approach for cancer drug delivery

Madhan, S., Dhar, R., & Devi, A. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02752j · Cited by 73 · see citing works

Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities

Isazadeh, H., Oruji, F., Shabani, S., Behroozi, J., Nasiri, H., Isazadeh, A., & Akbari, M. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08749-y · Cited by 72 · see citing works

Application of Emerging Plant-Derived Nanoparticles as a Novel Approach for Nano-Drug Delivery Systems

Sarvarian, P., Samadi, P., Gholipour, E., Asenjan, K. S., Hojjat‐Farsangi, M., Motavalli, R., Khiavi, F. M., & Yousefi, M. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1891094 · Cited by 69 · see citing works

Plant-Derived Exosome-Like Nanoparticles: Emerging Nanosystems for Enhanced Tissue Engineering

Feng, H., Yue, Y., Zhang, Y., Liang, J., Liu, L., Wang, Q., Feng, Q., & Zhao, H. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s448905 · Cited by 67 · see citing works

β-Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse Model

Ashihara, E., Kawata, E., Nakagawa, Y., Shimazaski, C., Kuroda, J., Taniguchi, K., Uchiyama, H., Tanaka, R., Yokota, A., Takeuchi, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1350 · Cited by 66 · see citing works

Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52

Shehata, M., Bièche, I., Boutros, R., Weidenhofer, J., Fanayan, S., Spalding, L. J., Zeps, N., Byth, K., Bright, R. K., Lidereau, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4994 · Cited by 66 · see citing works

HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development

Hack, S. P., Bruey, J., & Koeppen, H. (2014) · Oncotarget · doi:10.18632/oncotarget.2003 · Cited by 65 · see citing works

Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth

Zhou, Y., Yuan, Y., Liu, M., Hu, X., Quan, Y., & Chen, X. (2019) · ExRNA · doi:10.1186/s41544-019-0034-9 · Cited by 63 · see citing works

The Advances and Challenges in Utilizing Exosomes for Delivering Cancer Therapeutics

Yang, M., & Wu, S. Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00735 · Cited by 59 · see citing works

‘Golden’ exosomes as delivery vehicles to target tumors and overcome intratumoral barriers: in vivo tracking in a model for head and neck cancer

Cohen, O. M., Betzer, O., Elmaliach-Pnini, N., Motiei, M., Sadan, T., Cohen-Berkman, M., Dagan, O., Popovtzer, A., Yosepovich, A., Barhom, H., et al. (2021) · Biomaterials Science · doi:10.1039/d0bm01735c · Cited by 59 · see citing works

Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression

Kase, Y., Uzawa, K., Wagai, S., Yoshimura, S., Yamamoto, J.-I., Toeda, Y., Okubo, M., Eizuka, K., Ando, T., Nobuchi, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85242-1 · Cited by 58 · see citing works

RNAi-based Therapeutics Targeting Survivin and PLK1 for Treatment of Bladder Cancer

Seth, S., Matsui, Y., Fosnaugh, K. L., Liu, Y., Vaish, N. K., Adami, R. C., Harvie, P., Johns, R. E., SEVERSON, G. M., Brown, T., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.21 · Cited by 56 · see citing works

MYC addiction: a potential therapeutic target in MM

Kuehl, W. M., & Bergsagel, P. L. (2012) · Blood · doi:10.1182/blood-2012-08-445262 · Cited by 55 · see citing works

Stressors alter intercellular communication and exosome profile of nasopharyngeal carcinoma cells

Harmati, M., Tarnai, Z., Decsi, G., Körmöndi, S., Szegletes, Z., Janovák, L., Dékány, I., Saydam, O., Gyukity-Sebestyén, E., Dobra, G., et al. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12486 · Cited by 53 · see citing works

Emerging role of exosomes in cancer therapy: progress and challenges

Li, J., Wang, J., & Chen, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02215-4 · Cited by 278 · see citing works

Exosomes in Precision Oncology and Beyond: From Bench to Bedside in Diagnostics and Therapeutics

Youssef, E. M., Palmer, D., Fletcher, B., & Vaughn, R. (2025) · Cancers · doi:10.3390/cancers17060940 · Cited by 82 · see citing works

Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing

Balaraman, A. K., Babu, M. A., Moglad, E. H. O., Mandaliya, V. B., Rekha, M. M., Gupta, S., Prasad, G. V. S., Kumari, M., Chauhan, A. S., Ali, H., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155785 · Cited by 44 · see citing works

Unlocking the potential of exosomes ‘extracellular vesicles’: drug delivery advancements and therapeutics in ocular diseases

Verma, N., Arora, S., Singh, A. K., & Ahmed, J. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00097a · Cited by 40 · see citing works

Emerging Biomimetic Drug Delivery Nanoparticles Inspired by Extracellular Vesicles

Sundaram, V., & Aryal, S. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70025 · Cited by 40 · see citing works

Dual Approaches in Oncology: The Promise of siRNA and Chemotherapy Combinations in Cancer Therapies

Sousa, C., & Videira, M. (2025) · Onco · doi:10.3390/onco5010002 · Cited by 34 · see citing works

Mesenchymal stromal cell–derived extracellular vesicles in regenerative medicine: Standardisation, bioengineering and clinical translation

Shimizu, Y., Inoue, Y., Matsuura, N., Ishii, T., Sowa, Y., Sunami, H., & Ntege, E. H. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.101058 · Cited by 29 · see citing works

Exosomes in Clinical Laboratory: From Biomarker Discovery to Diagnostic Implementation

Aljohani, M. A. (2025) · Medicina · doi:10.3390/medicina61111930 · Cited by 24 · see citing works

Advances in Lipid-Based Nanomedicine: Pathway Specific siRNA Therapy and Optimizing Delivery for Hepatocellular Carcinoma

Thalij, K. M., You, H. W., Aher, K. B., Bhavar, G. B., Kumbhar, S. T., & Habeeb, M. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s532246 · Cited by 14 · see citing works

A review on mesenchymal stem cells and their secretome in hepatocellular carcinogenesis and its related signaling pathways: recent update

Jayachandran, J., Rithi, A. T., Mitra, A., Radhakrishnan, A., Banerjee, A., & Duttaroy, A. K. (2025) · Discover Oncology · doi:10.1007/s12672-025-03088-9 · Cited by 12 · see citing works

“Mesenchymal stem cell-derived exosomes (MSC-exosomes) in hematology: From mechanisms to clinical breakthroughs”

Ahmad, I. S., Hussein, A., Kanabar, B. K., Kumar, A., Ramachandran, T., Shankhyan, A., Karthikeyan, A. S., Thatoi, D. N., Aminov, Z., Samarkhazan, H. S., et al. (2025) · Cellular Immunology · doi:10.1016/j.cellimm.2025.104986 · Cited by 11 · see citing works

Targeting LINC02544/miR-497-5p/CAPRIN1 axis via exosome-based siRNA to overcome immunotherapy resistance in triple-negative breast cancer

Lian, B., Li, J., Tang, S., Li, J., & Li, J. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01336-w · Cited by 10 · see citing works

Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma

Jin, P., & Bai, X. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.01.015 · Cited by 9 · see citing works

Knocking on Cells’ Door: Strategic Approaches for miRNA and siRNA in Anticancer Therapy

Serra, M., Buccellini, A., & Paolillo, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178703 · Cited by 9 · see citing works

Mesenchymal Stromal/Stem Cells (MSCs) in Cancer Therapy: Advanced Therapeutic Strategies Towards Future Clinical Translation

Kucharczyk, H., Tarnowski, M., & Tkacz, M. (2025) · Molecules · doi:10.3390/molecules30244808 · Cited by 9 · see citing works

Galectins and Host–Pathogen Interactions: The roles in viral infections

Wang, S.-F., Chen, H.-L., & Liu, F. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101911 · Cited by 8 · see citing works

Bioengineered Tumor‐Derived Extracellular Vehicles Suppressed Colorectal Cancer Liver Metastasis and Bevacizumab Resistance

Wang, J., Liu, C., Wang, P., Liu, Z., Hu, W., Lv, Z., Huang, C., & Yao, X. (2025) · Advanced Science · doi:10.1002/advs.202417714 · Cited by 7 · see citing works

Recent Breakthroughs in Exosome-Based Drug Delivery: A Comprehensive Review for Cancer Therapy

Shah, D., Gandhi, S., Shah, S., & Patel, K. (2025) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2025.0050 · Cited by 7 · see citing works

Small interfering RNA (siRNA) based therapies for cancer treatment: A special focus on cervical cancer

Bavishi, L., Butani, S., & Patel, S. S. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178198 · Cited by 7 · see citing works

Coptis chinensis extracellular vesicles loaded with CA1-siRNA promote endothelial repair and stent restenosis therapy by regulating the PADI2 and NF-κB pathway

Wang, X., Liu, Y., Li, W., Hao, J., Zhao, Z., Fan, H., Wu, X., Liu, X., Xu, H., Yu, T., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04092-z · Cited by 7 · see citing works

Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications

Shqair, L., Draw, I., Maya, T., Bunick, C. G., Akbarialiabad, H., Schlesinger, T. E., Damiani, G. B., Ghannoum, M. A., & Grada, A. A. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111438 · Cited by 6 · see citing works

The roles of plant-derived extracellular vesicles in cancer: Focusing on drug delivery, anti-cancer immunity and renin-angiotensin system

Cai, X., Wang, C., Xu, Z., Liu, W., Liu, H., Zhou, Z., Yan, Y., & Wang, X. (2026) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203261432784 · Cited by 5 · see citing works

Smart nano exosomes as precision drug carriers: a new frontier in targeted treatment of oral cancer

Mousavi, S. M., Abbasifard, M., Abbasi, R., Tivay, S., Hosseini, H., Taghipoor, M., Kalashgrani, M. Y., Aljabri, M. D., Rahman, M. M., Chiang, W., et al. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125923 · Cited by 4 · see citing works

The Antiangiogenic Effect of VEGF-A siRNA-FAM-Loaded Exosomes

Hur, W., Bhujel, B., Oh, S., Lee, S., Chung, H. S., Park, J. H., & Kim, J. Y. (2025) · Bioengineering · doi:10.3390/bioengineering12090919 · Cited by 4 · see citing works

Targeting tumor immune evasion: the role of PD-L1 siRNA in advancing cancer immunotherapy

Younis, S. M. D., Shareef, A., Bishoyi, A. K., Oweis, R. J., Malathi, H., Singh, A., Sahoo, S., Chauhan, A. S., Sameer, H. N., Yaseen, A., et al. (2025) · Medical Oncology · doi:10.1007/s12032-025-03025-4 · Cited by 4 · see citing works

Targeted Drug Delivery System for Pulmonary Fibrosis: Design and Development of Biomaterials

Liu, J., Pan, Z., Khan, A., & Li, H. (2025) · BIO Integration · doi:10.15212/bioi-2025-0016 · Cited by 3 · see citing works

The role of circular RNAs in gastric Cancer: Focusing on autophagy, EMT, and their crosstalk

Bakhti, S. Z., Latifi‐Navid, S., Pahlevan, A. D., Sarabi, L., & Safaralizadeh, R. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102169 · Cited by 2 · see citing works

siRNA-based Nanocarriers for Targeted Therapy in Prostate Cancer: Implications for Male Fertility Preservation

Jangde, K. K., Sharma, R., Mishra, D. K., & Mishra, P. K. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104543 · Cited by 2 · see citing works

Mitochondrial dynamics in cisplatin resistance: molecular mechanisms and therapeutic targeting

Huang, W., Sun, W., Yang, Z., Li, Y., & Wang, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1736487 · Cited by 2 · see citing works

Exosomes-loaded with traditional Chinese medicine constituents: a novel therapeutic avenue for aplastic anemia

Zhang, G.-K., & Zhou, F. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01330-2 · Cited by 2 · see citing works

Therapeutic Exosomes for Rare Cancers: Advances and Clinical Translation

Unnikrishnan, K., Mahesh, A. V., & Kumar, R. M. R. (2026) · ChemMedChem · doi:10.1002/cmdc.202500653 · Cited by 2 · see citing works

Exosome Engineering for Blocking Gut Dysbiosis and Inducing Cell Death Mechanisms in Glioblastoma Multiforme

Muraleedharan, A., Rangavajhula, K., & Ray, S. K. (2026) · Cells · doi:10.3390/cells15050422 · Cited by 2 · see citing works

Nanotechnology in lung cancer: Enhancing targeted drug delivery and diagnostic precision

Halim, P., Tan, M.-S., Yumiko, Lu, F. C., Dalimunthe, A., Tallei, T. E., Rahman, M., Rani, A., Kim, B., Ribeiro, R. I. M. D. A., et al. (2026) · Results in Surfaces and Interfaces · doi:10.1016/j.rsurfi.2026.100773 · Cited by 2 · see citing works

Enhanced Auricular Cartilage Regeneration via 3D‐Printed Hydrogel With miR‐92a‐3p‐Enriched Platelet‐Rich Plasma‐Derived Extracellular Vesicles

Hua, S., Zhang, H., Gu, J., Yin, M., Wu, S., He, C., Liu, H., Zhou, H., Guo, R., Shi, Y., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505389 · Cited by 2 · see citing works

Stimuli-Responsive Polyethylenimine Derivatives as Carriers for siRNA Delivery: Current Solutions and Future Perspectives

Kołacki, O., Trzciński, S., & Chmielewski, M. K. (2026) · ACS Omega · doi:10.1021/acsomega.6c00666 · Cited by 2 · see citing works

Small Interfering RNA (siRNA) for Cardiorenal Disease: Mechanistic Insights from Preclinical and Clinical Studies

Wadehra, S., Singh, S., Kaur, S., Kaur, A., & Singh, T. G. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10649-4 · Cited by 1 · see citing works

Breakthroughs in the nanoparticle-mediated delivery of siRNA for breast cancer treatment

Aleixo, D. T., da Cruz-Cazarim, E. L. C., Ferreira, K. C. B., Grossi, L. D. N., Braz, W. R., da Silva, N. P., Pittella-Silva, F., Dias, M. F., Fialho, S. L., Tavares, G. D., et al. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2567842 · Cited by 2 · see citing works

Small Interfering RNA Carriers for Oncotherapy: A Preclinical Overview

Aranda‐Lara, L., Escudero-Castellanos, A., Trujillo-Nolasco, M., Morales-Ávila, E., Ocampo‐García, B., Oros‐Pantoja, R., Monroy, V. S., & Isaac‐Olivé, K. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111408 · Cited by 1 · see citing works

Advances in the use of exosomes for the diagnosis and treatment of ovarian cancer

Chen, J., & Tan, Q. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-04135-z · Cited by 1 · see citing works

Disruption of LINC00265/miR-101-3p axis using siRNA suppresses growth and promotes apoptosis in laryngeal cancer cells

Maghsudlu, M., Razipour, M., Ghadami, E., Karimi, E., Damavandi, E., Saeedi, N., Bioki, F. Y., Kabuli, M., & Ghadami, M. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102405 · Cited by 1 · see citing works

Therapeutic potential of exosomes in malignancies: From drug delivery to clinical application

Bibi, R., Koley, A., & Sarkar, K. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156381 · Cited by 1 · see citing works

Emerging strategies in exosome engineering: From cellular preconditioning to hybridization for targeted therapeutics

Belali, R., & Sameri, M. J. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153533 · Cited by 1 · see citing works

Unveiling the Potential of Plant-derived Exosomes: A Comprehensive Review

Jaiswal, S., Sethi, M., Rana, R., Tripathi, S., Trivedi, A. K., & Chourasia, M. K. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03407-5 · Cited by 1 · see citing works

Circulating lncRNA as Biomarkers and Therapeutics in Oral Cancer: Silent Scripts with Loud Impact

Bhattacharyya, R., Biswas, C., Khan, M. S., Dutta, S., & Sur, S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11968-8 · Cited by 1 · see citing works

The role of targeted exosomes in improving drug delivery in breast cancer: challenges and prospects

Moghadam, M. Z., Shafieesabet, M., Jamshidi, N., & Jamshidi, N. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11635-y · Cited by 1 · see citing works

Plant-derived exosome-like nanovesicles: From biological characteristics to precision medicine applications as multifunctional delivery platforms

Ye, Y., Jia, Z., Feng, J., Sun, C., Chen, L., Lei, L., Zhu, Z., & Liu, L. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100848 · Cited by 1 · see citing works

Reprogramming the tumor microenvironment via TFF3 targeting: a potential novel avenue to boost CAR-T cell therapy in solid tumors

Rahimi, A., Solgi, G., Safarzadeh, M., Mohammadi, P., & Rastegari‐Pouyani, M. (2026) · Cancer Gene Therapy · doi:10.1038/s41417-026-01040-9 · Cited by 1 · see citing works

Long non-coding RNAs in glioblastoma: from molecular drivers to therapeutic targets

Elemam, N. M., Sweillam, J. H., El-Sherif, Y., Youssef, Y. A., Ismail, H. M., Assal, R. A., & Youness, R. A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1887815 · Cited by 1 · see citing works

Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges

Lunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2 · see citing works

Non-coding RNAs in laryngeal squamous cell carcinoma: diagnostic biomarkers and emerging exosome-based therapeutic strategies

Elgörmüş, M. N., Biltekin, B., & İbas, M. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04106-0

Recent advances in exosome-based therapies for prostate cancer: targeting oncoviral and epigenetic pathways

Noufel, A., Guemih, I., & Ennaji, M. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30225-1.00060-9

MicroRNA mediated signaling and metabolic reprogramming in oral squamous cell carcinoma

Patel, G., & Harihar, S. (2026) · Medical Oncology · doi:10.1007/s12032-026-03263-0

Dissecting tumor heterogeneity in colorectal cancer: uncovering the role of BCL2L1+ cells through single-cell analysis

Zhu, G., Liu, Y., Shi, Y., Qian, N., Song, C., Liu, X., Xiahou, Z., Xiong, Z., & Hu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1742767

Ethical considerations, challenges, and the road ahead: exosomes in the next decade

Aditi, P., Srivastava, S., Singh, C., Ghodake, G., & Kim, D.-Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36390-0.00012-9

Exosome Engineering for Targeted Therapy: Tools and Techniques

Sharma, S., Mishra, A. C., Debnath, A., & Singh, R. K. (2026) · Current Drug Delivery · doi:10.2174/0115672018399550251030075217

RNA therapeutic targeting of recalcitrant and rare cancers

Ishola, A. A., Verusingam, N. D., & Lawal, B. (2026) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2026.1002373

Leveraging engineered small EVs to mitigate cancer pain: a new paradigm

Sarkar, S., Roy, S., & Choudhury, L. (2026) · Journal of Microencapsulation · doi:10.1080/02652048.2026.2677813

EGFR ‐Targeted RNA –Exosome Nanoparticles Delivering Paclitaxel Suppress Colorectal Cancer via PRELP Upregulation

Li, Q., Ji, Y., Zhen, Z., & He, Y. (2026) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.70111

Mesenchymal stem cell-derived exosomes as engineered nanocarriers for cancer stem cell targeting

Bhoi, S., Patil, V., Patil, N., Pawar, R., & Patil, G. (2026) · Next research. · doi:10.1016/j.nexres.2026.102059

Microfluidic Platforms for Exosome Engineering: Scalable Therapeutics for Cancer Immunotherapy and Infectious Diseases

Lee, M., Park, K., Kim, J., Hyun, K., Sathiyaseelan, A., & Park, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146298

Advances in applications of siRNA in cancer therapy: challenges and opportunities

Mehrparvar, M., Shabani, S., Oruji, F., Hajazimian, S., Nasiri, H., Khansalar, S., Behroozi, J., Isazadeh, A., & Akbari, M. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04497-0

Exosomes in cancer drug resistance: dual roles in therapy failure and emerging precision therapeutics

Tegegne, B. A., Belew, H., Teffera, Z. H., Belayneh, M., Abebaw, D., Fikrie, M., Jemal, M., Baylie, T., Tadesse, F., Wondm, S. A., et al. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04396-y

Exosome-mediated siRNA delivery in cancer: Loading strategies, targeting approaches, and therapeutic outcomes

El‐Sehrawy, A. A. M. A., Hussein, H. Y., Nematov, O. N., Baig, M. R., Patel, D. N., Nayak, P. P., Alkayyat, S., Bainsal, N., Singh, G., & Basunduwah, T. S. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00631-z

Revolutionizing lung cancer immunotherapy: Small interfering RNA-based gene silencing for immune checkpoint blockade

Saha, R., Kumar, S., Singh, R., Attri, R., & Kumar, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44585-9.00011-1

Brain‐Targeting siRNA Delivery to Tackle Alzheimer's Disease

Yang, Q., Chen, Z., Zhu, J., Chai, T., Tang, F., Fan, M., Li, Y., Chen, S., Liu, Y., & Zheng, M. (2026) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70076

Vectors Trgeting Hepatocyte: Reconstructive Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes

Yin, Y., Chun-tao, Y., Zheng, G. U. A. N., Yu, L., Chun-mei, L., Wang, D., & Yang, J. (2026) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-026-00826-0

Understanding the Potential of Antibody‐Drug Conjugates Functionalized Engineered Exosomes in Hepatocellular Carcinoma Therapy: A Comprehensive Narrative Review

Sarkar, S., Bose, A., Rajak, J., Mitra, A. K., Kumer, A., & Dhara, B. (2026) · Health Science Reports · doi:10.1002/hsr2.73289

Exosomes and Extracellular Vesicles in Oncology: Next-Generation Smart Nanocarriers for Precision Cancer Therapy

Khan, M. M. U., Khan, M. A., Azam, M., Afzal, M., & Alsahli, T. G. (2026) · Cells · doi:10.3390/cells15191812

Exosome-mediated siRNA delivery in cancer: Loading strategies, targeting approaches, and therapeutic outcomes

El‐Sehrawy, A. A. M. A., Hussein, H. Y., Nematov, O. N., Baig, M. R., Patel, D. N., Nayak, P. P., Alkayyat, S., Bainsal, N., Singh, G., & Basunduwah, T. S. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00631-z

Exosomes as Precision Nanocarriers: A Next-generation Approach to Targeted Cancer Therapy

Kumar, P., Diksha, Gautam, S., Zafar, M., Hussain, Z., & Verma, N. (2026) · Current Materials Science · doi:10.2174/0126661454435402260330092224

Exosomal nanocarriers for targeted drug delivery in cancer therapy

Atabi, F., Moassesfar, M., Bagherian, M., & Hashemi, M. (2026) · Discover Oncology · doi:10.1007/s12672-026-04663-4 · Cited by 3 · see citing works

Emerging role of exosomes in cancer therapy: progress and challenges

Li, J., Wang, J., & Chen, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02215-4 · Cited by 278 · see citing works

Harnessing exosomes for advanced drug delivery in cancer theranostics

Dhanawat, M., Garima, Wilson, K., Bhushan, B., Vohra, V., Nair, A. K., Chaubey, P., Mittal, N., & Girdhar, J. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126966 · Cited by 2 · see citing works